Finance
Results: 32605-32616 of 39786

Neuraptive Therapeutics, Inc. Announces Positive 24-Week Data for NTX-001 in the Phase 2 NEUROFUSE Study, Reinforcing Previously Announced Proof of Concept 12-Week Data

KBRA Releases Research: European Corporates: Muted Impact of Geopolitical Tensions on Energy, so Far






